CorCMR: Stress Cardiac MRI Uncovers Hidden Angina and Improves Quality of Life in Patients Without Obstructive Coronary Disease
Key Points: Stress cardiac MRI (CMR) enhanced diagnostic accuracy for patients with…
CELEBRATE: Early Pre-hospital Subcutaneous Zalunfiban Improves Coronary Patency and Outcomes in STEMI Without Increasing Severe Bleeding
Key Points: Early pre-hospital administration of subcutaneous zalunfiban improved coronary patency and…
Family-Based Intervention Reduced Blood Pressure in Adults in Rural China: The Healthy Family Program
Key Points: A community- and family-based intervention can reduce systolic blood pressure…
DASH Diet Patterned Groceries Help Reduce Blood Pressure in Black Adults: The GOFRESH Trial
Key Points: The GOFRESH trial, a parallel-group randomized study, was conducted to…
BETTER-BP: Offering Cash Incentives Improves Anti-Hypertensive Medication Adherence, But Not Blood Pressure Control
Key Points: Adherence to antihypertensive medications remains a persistent challenge in clinical…
FAVOR IV-QVAS: Angio-FFR–Guided CABG During Valve Surgery Improves Outcomes
Key Points: The FAVOR IV-QVAS trial tested the hypothesis physiology-guided coronary artery…
ABLATION Trial – Biatrial Ablation During Mitral Valve Surgery Better than LA Ablation Alone
Key Points: Persistent atrial fibrillation (AF) is common among patients with rheumatic…
PCSK9-inhibitors Do Not Reduce Early Cardiac Allograft Vasculopathy: The CAVIAR Trial
Key Points The CAVIAR trial enrolled recent heart transplant recipients to receive…
Oral KCl Supplementation Lowers Sodium Load and Blood Pressure in Hypertension: SSTT Trial
Key Points The See Sodium to Treat (SSTT) Trial tested whether isolated…
Two Factor XI Antibodies For the Prevention of Post- operative VTE: Results from ROXI-VTE-I and ROXI-VTE-II Trials
Key Points: ROXI-VTE-I and ROXI-VTE-II evaluated two distinct factor XI monoclonal antibodies…
Providing Healthy Food + Nutrition Counseling Improved Quality of Life in HF Patients: FOOD-HF Trial
Key Points: The FOOD‑HF Trial was a single center randomized trial that…
DR10624, a First-in-Class FGF21/GLUCAGON/GLP-1 Receptor Triple Agonist, Significantly REDUCED Triglycerides, Lipids, and Liver Fat in Patients with Severe HYPERTRIGLYCERIDEMIA
Key Points: DR10624 is a first-in-class triple agonist of the FGF21, glucagon,…
NEWTON-CABG: Evolocumab Did Not Improve Vein Graft Patency After CABG
Key Points: Saphenous vein graft (SVG) failure is common after coronary artery…
In-Hospital Dapagliflozin Does Not Reduce CV Death or Worsening HF in Two Months, but Meta-Analysis Signals Potential Early Benefit
Key Points: Dapagliflozin is a key component of GDMT for heart failure,…
AI-Powered Virtual Assistant Boosts GDMT Optimization. ASSIST-HF SIRIO
Key Points: Optimization of GDMT is critical, particularly in the initial months…
Sacubitril/Valsartan Outperforms Enalapril in HFrEF due to Chronic Chagas Cardiomyopathy (CCC): The PARACHUTE-HF Trial
Key Points: Chronic Chagas cardiomyopathy (CCC) patients are underrepresented in heart failure…
An AI-enabled Stethoscope for Early Detection of Cardiac Conditions Increases Detection: TRICORDER
Key Points: Eighty percent of HF cases are diagnosed only during emergency…
Home-Based Hypertension Care Significantly Lowers Blood Pressure in Rural South Africa: The IMPACT-BP Trial
Key Points: Hypertension (HTN) is a major driver of stroke and cardiovascular…
Zilebesiran May Benefit Selected Groups of Uncontrolled Hypertension with High CV Risk: KARDIA-3
Key Points: Many patients do not achieve BP goals in hypertension (HTN)…
Essence-TIMI 73b: Olezarsen Safely and Effectively Reduces Triglycerides in Patients With Moderate Hypertriglyceridemia and High CV Risk
Key Points: Olezarsen, an anti-sense oligonucleotide targeting APOC3 mRNA, is approved to…